Ventas, Inc.
$58.57B- Market cap
- $46.30B
- Debt
- +$13.01B
- Cash
- −$741.07M
Capital structure 78% equity / 22% debt · EV / Revenue 10.04x · EV / EBITDA 39.88x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $46.30B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2026 · Mkt cap
Decision snapshot: VTR stock price vs GCO: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at GCO's multiple
Needs GCO P/E.
Implied fair value · at VTR's multiple
Needs VTR P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: VTR FY 2025 (ended Dec 31, 2025) · GCO FY 2026 (ended Jan 31, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 78% equity / 22% debt · EV / Revenue 10.04x · EV / EBITDA 39.88x
Capital structure 99% equity / 1% debt · EV / Revenue 0.12x · EV / EBITDA 4.20x
VTR carries the larger enterprise value at $58.57B against $295.71M; GCO trades on the lower EV / Revenue multiple (0.12x vs 10.04x); GCO on the lower EV / EBITDA (4.20x vs 39.88x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Ventas, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Genesco Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.04x
0.01x
Net debt / EBITDA
Leverage against operating earnings
8.35x
-1.45x
Cash and equivalents
Liquid reserves on the balance sheet
$741.07M
$105.41M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
WELLTOWER INC.
VTR vs WELL
Sabra Health Care REIT, Inc.
VTR vs SBRA
NATIONAL HEALTH INVESTORS INC
VTR vs NHI
OMEGA HEALTHCARE INVESTORS INC
VTR vs OHI
FOOT LOCKER, INC.
VTR vs FL
SHOE CARNIVAL INC
VTR vs SCVL
CALERES INC
VTR vs CAL
Designer Brands Inc.
VTR vs DBI
SKECHERS USA INC
VTR vs SKX
$13.01B
$3.38M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.